UP!

ARRY $47.85   View long term graphs

Array BioPharma is a clinical stage publicly traded pharmaceutical company (NASDAQ:ARRY) that is included in the NASDAQ Biotechnology Index.


Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2020 2019-10-28 Future report Set alerts
Q4 2019 2019-08-12 Future report Set alerts
Q3 2019 2019-05-07 -0.17 -0.17
Q2 2019 2019-02-05 -0.05 -0.05
Q1 2019 2018-10-30 -0.12 -0.12
Q4 2018 2018-08-14 -0.25 -0.25
Q3 2018 2018-05-09 -0.11 -0.11
Q2 2018 2018-02-06 -0.17 -0.17
Q1 2018 2017-10-31 -0.22 -0.22
Q4 2017 2017-08-09 -0.17 -0.17

Ratings

2016-06-20 Reiterated Rating Leerink Swann Buy
2016-06-08 Reiterated Rating Cantor Fitzgerald Buy
2016-06-02 Initiated Coverage SunTrust Buy $7.00
2016-06-02 Initiated Coverage SunTrust Banks Inc. Buy $7.00
2016-05-19 Reiterated Rating Leerink Swann Outperform $6.00
2016-05-05 Reiterated Rating Leerink Swann Buy $6.00
2016-05-04 Reiterated Rating Cantor Fitzgerald Buy
2016-05-04 Reiterated Rating Jefferies Group Buy
2016-04-02 Reiterated Rating Piper Jaffray Buy
2016-04-02 Reiterated Rating Piper Jaffray Cos. Buy
2016-02-03 Lower Price Target Stifel Nicolaus Buy $8.00 to $7.00
2016-02-02 Reiterated Rating Cantor Fitzgerald Buy
2015-12-17 Reiterated Rating Leerink Swann Outperform $9.00 to $6.00
2015-12-17 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-12-16 Reiterated Rating Piper Jaffray Buy
2015-09-29 Reiterated Rating Piper Jaffray Buy
2015-09-29 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-07-23 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-07-22 Reiterated Rating Piper Jaffray Buy
2015-06-02 Set Price Target Piper Jaffray Buy $15.00
2015-02-18 Boost Price Target Piper Jaffray Overweight $9.00 to $15.00
2015-01-26 Set Price Target Cantor Fitzgerald Buy $13.00
2015-01-26 Boost Price Target JPMorgan Chase & Co. Overweight $8.00 to $9.00
2015-01-26 Upgrade Jefferies Group Buy $9.00 to $10.00
2015-01-26 Boost Price Target Stifel Nicolaus Buy $6.00 to $9.00
2014-12-05 Boost Price Target Jefferies Group Buy $7.00 to $9.00
2014-08-13 Reiterated Rating Leerink Swann Outperform $8.00 to $6.00
2014-05-29 Initiated Coverage Cantor Fitzgerald Buy $9.00
2013-11-01 Boost Price Target BMO Capital Markets Market Perform $3.00 to $4.00
2013-08-09 Reiterated Stifel Buy $7 to $8
2010-07-23 Upgrade UBS Neutral to Buy $4.25
2010-04-22 Downgrade UBS Buy to Neutral
2009-11-05 Upgrade UBS Neutral to Buy
2009-09-04 Downgrade Robert W. Baird Outperform to Neutral $10 to $3
2009-09-04 Downgrade Leerink Swann Outperform to Mkt Perform $6 to $2
2009-09-04 Downgrade Boenning & Scattergood Outperform to Neutral
2009-06-17 Initiated Boenning & Scattergood Outperform $6
2008-05-07 Reiterated Rodman & Renshaw Mkt Outperform $18 to $15
2008-02-07 Initiated William Blair Outperform
2007-12-20 Reiterated Collins Stewart Buy $17 to $16
2007-12-04 Initiated Morgan Joseph Buy $16
2007-11-07 Reiterated Collins Stewart Buy $20 to $17
2007-10-09 Initiated Lehman Brothers Overweight $16
2007-08-13 Initiated Rodman & Renshaw Mkt Outperform $18
2007-05-23 Initiated JP Morgan Overweight
2007-01-04 Reiterated Piper Jaffray Outperform $14 to $20
2016-06-20 Reiterated Rating Leerink Swann Buy
2016-06-08 Reiterated Rating Cantor Fitzgerald Buy
2016-06-02 Initiated Coverage SunTrust Buy $7.00
2016-06-02 Initiated Coverage SunTrust Banks Inc. Buy $7.00
2016-05-19 Reiterated Rating Leerink Swann Outperform $6.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Redmile Group, LLC 15.20%  (19150650) ARRY / FOLD /
BVF PARTNERS L P/IL 5.60%  (7058997) ARQL / ARRY / CAPS / CCXI / CNCE / CTIC / INFI / LGND / NBIX / ONTY / PTN / RGDO / RGEN / RIGL / TRGT / XENE /
ARRAY BIOPHARMA INC 1.28%  (1609560) ARRY / LOXO /
KOCH KEVIN President, CSO 0.62%  (786917) ARRY / SGNL /
CONWAY ROBERT CEO 0.50%  (633386) ABIO / ARRY /
CARUTHERS MARVIN H 0.21%  (269040) ARRY /
Squarer Ron CEO 0.17%  (211575) ARRY /
Sandor Victor Chief Medical Officer. 0.17%  (210086) ARRY /
Robbins Andrews R SVP, Commercial Operations 0.13%  (159467) ARRY /
CARRUTHERS MICHAEL CFO 0.09%  (112265) ARRY /
Saccomano Nicholas A CSO 0.04%  (55278) ARRY /
MOORE JOHN R VP, General Counsel 0.03%  (40102) ARRY /
Haddock Jason CFO 0.02%  (28868) ARRY /
VAN LUNSEN GIL J 0.02%  (19297) ARRY / MTSI / OKS /
LEFKOFF KYLE 0.01%  (17720) ARRY / SGNL /
Fyfe Gwen A. 0.01%  (10000) ARRY / INFI / ONTY /
BAUM CHARLES M 0.01%  (10000) ARRY / MRTX /
Orwin John A 0.01%  (10000) AFFY / ARRY / RLYP / SGEN /
SNITMAN DAVID COO and VP, Business Devel. 0.01%  (7477) ARRY /

Comments